CPHI JAPAN 2023安排会议
Korea Science Day 2023安排会议
MAGHREB PHARMA Expo 2023安排会议
FCE Pharma 2022安排会议
CPhI North America安排会议
CPhI Japan Connect安排会议
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global’s Sustainability Yearbook for the 3rd year
Expert statement by Srividya Ramakrishnan, Head, API process engineering, Dr. Reddy’s Laboratories. Published in CHE Manager
Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner to pharma companies worldwide. Dr. Reddy's API business thrives on the deep technical strengths proven over the last three decades in developing and manufacturing complex APIs.
We focus our work on being first to market with products that are difficult to make. We follow the latest quality, safety, and productivity standards as per the ever-growing market needs. The success of our research organization is testimony to the fact that we have over 60+ active pharmaceutical ingredients (APIs), 170 ANDAs, over 500 DMFs, and 86 patents filed in the last five years.
Follow this page to explore how our offerings can accelerate your formulation success